Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Planned sale General Counsel sold 1,878 shares at $39.83 ($74,801)
  2. 4 Planned sale Chief Financial Officer sold 2,170 shares at $39.83 ($86,431)
  3. 4 Planned sale Kelsey Stephen Michael sold 4,289 shares at $39.83 ($170,831)
  4. 4 Planned sale Chief Medical Officer sold 2,173 shares at $39.83 ($86,551)
  5. 4/A Derivatives Options or other derivatives
  6. 4 Planned sale General Counsel sold 2,041 shares at $38.71 ($79,008)
  7. 4 Planned sale General Counsel sold 1,458 shares at $39.04 ($56,921)
  8. 4 Planned sale GOLDSMITH MARK A sold 11,738 shares at $39.04 ($458,255)
  9. 4 Planned sale Chief Financial Officer sold 1,864 shares at $39.04 ($72,771)
  10. 4 Planned sale Chief Operating Officer sold 3,058 shares at $39.04 ($119,385)
  11. 4 Planned sale Kelsey Stephen Michael sold 3,294 shares at $39.04 ($128,599)
  12. 4 Gift Wang Xiaolin gave 2,718 shares (gift)
  13. 4 Grant or award General Counsel acquired 22,000 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 20,400 shares (grant or award)
  15. 4 Grant or award Kelsey Stephen Michael acquired 36,600 shares (grant or award)
  16. 4 Grant or award Chief Operating Officer acquired 28,600 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 20,800 shares (grant or award)
  18. 4 Grant or award Wang Xiaolin acquired 19,000 shares (grant or award)
  19. 4 Grant or award GOLDSMITH MARK A acquired 97,400 shares (grant or award)
  20. 4 Planned sale General Counsel sold 2,406 shares at $40.50 ($97,443)

Page 6 of 21 · 414 filings